Lung deposition of inhaled colistimethate sodium in cystic fibrosis patients

S. Su, T. Riccobene, C. Scott (Jersey City, United States Of America)

Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Session: Cystic fibrosis: basic science, physiology and clinical aspects
Session type: Poster Discussion
Number: 1975
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Su, T. Riccobene, C. Scott (Jersey City, United States Of America). Lung deposition of inhaled colistimethate sodium in cystic fibrosis patients. Eur Respir J 2014; 44: Suppl. 58, 1975

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung clearance index predicts pulmonary exacerbations in cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014

Screening colonoscopy in adults with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

Lung MRI findings in children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014

Inflammatory biomarkers in urine of cystic fibrosis patients
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014


Lung Clearance Index (LCI) and FEV1 on the evaluation of the effect of tobramycin solution for inhalation (TIS) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014


Cystic fibrosis
Source: Eur Respir Mon; 2009: 45: 32–45
Year: 2009

Cystic fibrosis
Source: Annual Congress 2004 - Paediatric year in review
Year: 2004

Cystic fibrosis
Source: Eur Respir Mon; 2010: 47: 225–239
Year: 2010

Cystic fibrosis
Source: Eur Respir Monogr 2017; 77: 25-37
Year: 2017


Cystic fibrosis
Source: Eur Respir Monogr 2017; 77: 167-180
Year: 2017


Cystic fibrosis
Source: Annual Congress 2012 - Maurizio Vignola Award for Innovation in Pneumology Ceremony (supported by Chiesi Foundation) followed by Clinical Year in Review I
Year: 2012


Cystic fibrosis
Source: Annual Congress 2013 –Paediatric Year in Review
Year: 2013


Cystic fibrosis
Source: ERS Course 2015
Year: 2015

Cystic fibrosis
Source: Eur Respir Monogr 2013; 62: 54-69
Year: 2013


Cystic fibrosis
Source: School Course 2014 - Pulmonary Rehabilitation
Year: 2014

Cystic fibrosis
Source: International Congress 2014 – Paediatric Year in Review
Year: 2014



Adaptation of prevotella during acute infectious pulmonary exacerbation
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Safety, tolerability and efficacy of intravenous aminophylline in adult patients with pulmonary exacerbations of cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

Clinical value of lung clearance index (LCI) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014